(Penn State) Melanoma patients who took a specific type of beta blocker while receiving immunotherapy lived longer than patients who received immunotherapy alone, according to researchers.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2qGYlpB
No comments:
Post a Comment